by Admin | Apr 18, 2024 | FibroFighters in the News
During an interview conducted by Dr. Kent, Dr. Tasse emphasized the significance of educating the community about lesser-known therapies. At FibroFighters, our mission is to increase awareness about Fibrolamellar, and we strongly believe that this understanding can... by Admin | Oct 26, 2023 | FibroFighters in the News
We are excited to announce the expansion of our collaboration with BostonGene. BostonGene is a leading provider of AI-driven molecular and immune profiling solutions. FibroFighters began working with this innovative company about a year and half ago. From the... by Admin | Aug 7, 2023 | FibroFighters in the News
Last week, our amazing Medical Director Dr. Paul Kent was a special guest on an episode of TARGET: Cancer Podcast with Dr. Sanjay Juneja, the “OncDoc.” In the discussion, Dr. Kent sheds light on the unique challenges faced by patients with fibrolamellar... by Admin | Jan 27, 2023 | FibroFighters in the News
The Cardiovascular Learning Network recently featured Dr. Jordan Tasse in a conversation on their podcast. Check out the full conversation at the link here:... by Admin | Dec 11, 2022 | FibroFighters in the News
xCures partners with FibroFighters to launch a real-time learning platform for Fibrolamellar Hepatocellular... by Admin | Nov 22, 2022 | FibroFighters in the News
A Temecula father who lost to his son to cancer has teamed with a prominent oncologist in Long Beach to find a cure or treatment for the extremely rare disease. 